rs76963591

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006017.3(PROM1):​c.228G>A​(p.Leu76Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.024 in 1,490,096 control chromosomes in the GnomAD database, including 589 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 148 hom., cov: 32)
Exomes 𝑓: 0.023 ( 441 hom. )

Consequence

PROM1
NM_006017.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.432

Publications

6 publications found
Variant links:
Genes affected
PROM1 (HGNC:9454): (prominin 1) This gene encodes a pentaspan transmembrane glycoprotein. The protein localizes to membrane protrusions and is often expressed on adult stem cells, where it is thought to function in maintaining stem cell properties by suppressing differentiation. Mutations in this gene have been shown to result in retinitis pigmentosa and Stargardt disease. Expression of this gene is also associated with several types of cancer. This gene is expressed from at least five alternative promoters that are expressed in a tissue-dependent manner. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
PROM1 Gene-Disease associations (from GenCC):
  • retinal macular dystrophy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 41
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy 12
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 4-16038994-C-T is Benign according to our data. Variant chr4-16038994-C-T is described in ClinVar as Benign. ClinVar VariationId is 95331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.432 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0672 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PROM1NM_006017.3 linkc.228G>A p.Leu76Leu synonymous_variant Exon 3 of 28 ENST00000447510.7 NP_006008.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PROM1ENST00000447510.7 linkc.228G>A p.Leu76Leu synonymous_variant Exon 3 of 28 1 NM_006017.3 ENSP00000415481.2

Frequencies

GnomAD3 genomes
AF:
0.0350
AC:
5308
AN:
151868
Hom.:
146
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0693
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0270
Gnomad ASJ
AF:
0.0331
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.0370
Gnomad FIN
AF:
0.00627
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0230
Gnomad OTH
AF:
0.0283
GnomAD2 exomes
AF:
0.0211
AC:
3360
AN:
159262
AF XY:
0.0217
show subpopulations
Gnomad AFR exome
AF:
0.0567
Gnomad AMR exome
AF:
0.0132
Gnomad ASJ exome
AF:
0.0296
Gnomad EAS exome
AF:
0.00207
Gnomad FIN exome
AF:
0.00755
Gnomad NFE exome
AF:
0.0214
Gnomad OTH exome
AF:
0.0225
GnomAD4 exome
AF:
0.0228
AC:
30467
AN:
1338112
Hom.:
441
Cov.:
29
AF XY:
0.0229
AC XY:
15101
AN XY:
659890
show subpopulations
African (AFR)
AF:
0.0592
AC:
1695
AN:
28654
American (AMR)
AF:
0.0161
AC:
469
AN:
29142
Ashkenazi Jewish (ASJ)
AF:
0.0296
AC:
671
AN:
22690
East Asian (EAS)
AF:
0.00227
AC:
79
AN:
34864
South Asian (SAS)
AF:
0.0326
AC:
2098
AN:
64264
European-Finnish (FIN)
AF:
0.00700
AC:
342
AN:
48844
Middle Eastern (MID)
AF:
0.0404
AC:
215
AN:
5320
European-Non Finnish (NFE)
AF:
0.0222
AC:
23304
AN:
1049608
Other (OTH)
AF:
0.0291
AC:
1594
AN:
54726
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.416
Heterozygous variant carriers
0
1322
2644
3965
5287
6609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
978
1956
2934
3912
4890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0350
AC:
5318
AN:
151984
Hom.:
148
Cov.:
32
AF XY:
0.0342
AC XY:
2540
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.0694
AC:
2875
AN:
41454
American (AMR)
AF:
0.0269
AC:
411
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
115
AN:
3472
East Asian (EAS)
AF:
0.00270
AC:
14
AN:
5180
South Asian (SAS)
AF:
0.0372
AC:
179
AN:
4806
European-Finnish (FIN)
AF:
0.00627
AC:
66
AN:
10528
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0230
AC:
1563
AN:
67966
Other (OTH)
AF:
0.0280
AC:
59
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
251
503
754
1006
1257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0290
Hom.:
37
Bravo
AF:
0.0386
Asia WGS
AF:
0.0310
AC:
107
AN:
3446

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 14, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Stargardt disease 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Retinal macular dystrophy type 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Cone-rod dystrophy 12 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.40
DANN
Benign
0.30
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76963591; hg19: chr4-16040617; COSMIC: COSV71699385; COSMIC: COSV71699385; API